PRESS RELEASE published on 10/10/2024 at 12:22, 1 year 1 month ago Closure of IT-IS International Novacyt announces closure of IT-IS International subsidiary to improve EBITDA. Retains IP for ongoing dispute with Roche Diagnostics. Focus on future growth and cost reduction EBITDA Closure Novacyt IT-IS International IP Dispute
BRIEF published on 10/01/2024 at 13:41, 1 year 2 months ago Novacyt Provides Monthly Update on Liquidity Agreement and Total Voting Rights Shareholders Voting Rights Liquidity Agreement INVEST SECURITIES Novacyt
BRIEF published on 10/01/2024 at 13:41, 1 year 2 months ago Novacyt publie une mise à jour mensuelle sur l'accord de liquidité et le total des droits de vote Actionnaires Droit De Vote Novacyt Accord De Liquidité Investir Dans Des Titres
PRESS RELEASE published on 10/01/2024 at 13:39, 1 year 2 months ago Information mensuelle sur le contrat de liquidité et sur le nombre total de droits de vote Novacyt publie son bilan mensuel du contrat de liquidité et du nombre total de droits de vote. Consultez les détails de l'opération et les contacts clés de l'entreprise Contrat Droits De Vote Liquidité Actions Ordinaires Novacyt
PRESS RELEASE published on 10/01/2024 at 13:36, 1 year 2 months ago Liquidity Agreement Monthly Update and Total Voting Rights Novacyt provides a monthly update on its liquidity agreement with Invest Securities SA and discloses total voting rights. The agreement involves purchasing and selling ordinary shares under French law Liquidity Agreement Total Voting Rights French Law Novacyt Invest Securities SA
PRESS RELEASE published on 09/17/2024 at 10:28, 1 year 2 months ago Lancement du nouveau site web Novacyt annonce le lancement de son nouveau site web, offrant un large portefeuille de services de diagnostic moléculaire. Visitez www.novacyt.com pour en savoir plus Technologies Investisseurs Site Web Diagnostic Moléculaire Novacyt
BRIEF published on 09/17/2024 at 10:27, 1 year 2 months ago Novacyt Announces HY 2024 Results and Investor Webinar Financial Results Investor Presentation Webinar Diagnostics Novacyt
BRIEF published on 09/17/2024 at 10:27, 1 year 2 months ago Novacyt annonce ses résultats du premier semestre 2024 et un webinaire destiné aux investisseurs Résultats Financiers Webinaire Presentation Aux Investisseurs Diagnostic Novacyt
PRESS RELEASE published on 09/17/2024 at 10:26, 1 year 2 months ago Launch of new website Novacyt S.A. announces the launch of its new website which better reflects the expanded Group following the acquisition of Yourgene Health. Visit novacyt.com for more information Intégration Molecular Diagnostics New Website Novacyt S.A. Yourgene Health
PRESS RELEASE published on 09/17/2024 at 10:24, 1 year 2 months ago Information sur les résultats du 1er semestre 2024 et présentation aux investisseurs Novacyt annonce ses résultats du 1er semestre 2024 et une présentation aux investisseurs le 26 septembre 2024. Webinaire interactif avec Lyn Rees et Steve Gibson Résultats Semestriels Webinaire Investisseurs Diagnostic Moléculaire Novacyt
Published on 12/05/2025 at 21:45, 23 minutes ago When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 38 minutes ago The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once
Published on 12/05/2025 at 21:20, 48 minutes ago Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Published on 12/05/2025 at 21:00, 1 hour 8 minutes ago The Repricing Event: Why Multiple Global Industries Are Suddenly Moving Toward SMX
Published on 12/05/2025 at 20:25, 1 hour 43 minutes ago The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others
Published on 12/05/2025 at 18:58, 3 hours 10 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 3 hours 53 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:46, 4 hours 22 minutes ago Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:18, 4 hours 50 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 4 hours 50 minutes ago The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 6 hours 57 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 6 hours 57 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 8 hours 10 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
